Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Spironolactone Tablet, Film Coated
Product Images NDC 70518-4470
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-4470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
This text provides data and statistics on a study involving Spironolactone and Placebo with 822 and 841 participants respectively. The study analyzed the data over consecutive months up to 42 months. The Log-rank p-value is reported as being less than 0.001, indicating a statistically significant result.*
Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
This text appears to be a structured data table containing information related to a subgroup analysis in a medical study. The data includes variables such as age, sex, race, left ventricular ejection fraction (LVEF), heart failure severity, presence of diabetes, creatinine levels, medication use (e.g., digoxin, ACE inhibitors, beta-blockers), and outcomes. The analysis also categorizes patients based on various criteria such as age, LVEF, race, heart failure type, and medication usage. The results compare different subgroups based on the specified variables and indicate the comparison between treatment outcomes with spironolactone and placebo.*
Remedy_label (Remedy Label)
This text provides information about a medication with the NDC number 70518-4470-00, manufactured by Zydus Pharmaceuticals. The medication is Spironolactone Tablet in 25 mg strength, with instructions to protect it from light, store at 20-25°C (68-77°F), and keep out of reach of children. The package contains 100 tablets. The usual dosage details can be found in the insert. Additionally, it mentions that the medication can be stored at excursions permitted to 15-30°C (59-86°F). The text also indicates details about repackaging by RemedyRepack Inc., located in Indiana, PA.*
Mm2 (Spironolactone 25mg 70518 4470 01)
This text is a medication label containing information about Spironolactone tablets. It includes details such as the National Drug Code (NDC) number, expiration date, manufacturer (Zydus Pharm), storage instructions, dosage information, and the name of the company that repackaged the medication (RemedyRepack Inc.). The label emphasizes protecting the medication from light, keeping it away from children, and storing it at a temperature between 20-25°C. The text also mentions that excursions in temperature are permitted within the range of 15-30°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
